Previous close | 2.9000 |
Open | 2.9800 |
Bid | 2.5000 |
Ask | 2.7600 |
Strike | 120.00 |
Expiry date | 2024-01-19 |
Day's range | 2.5600 - 2.9800 |
Contract range | N/A |
Volume | |
Open interest | 1.51k |
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.
In the CRL, the FDA asks AbbVie (ABBV) for some extra information about the pump device used to administer the Parkinson's disease medicine, ABBV-951.